BeiGene, Ltd. (BGNE)

BeiGene Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-784.43	-881.71	-2,003.82	-1,457.82	-1,624.97	-948.63
Depreciation & Amortization	92.96	87.68	66.28	46.46	31.79	18.62
Share-Based Compensation	380.96	367.62	303.16	240.71	183.48	134.15
Other Operating Activities	-591.74	-731.04	137.76	-128.08	126.24	45.59
Operating Cash Flow	-902.25	-1,157.45	-1,496.62	-1,298.72	-1,283.46	-750.27
Capital Expenditures	-597.56	-561.9	-325.43	-262.94	-117.51	-89.61
Change in Investments	283.02	656.27	1,546	955.51	-2,939.33	712.78
Other Investing Activities	-76.35	-34.37	-143.67	-51.91	-111.53	-69
Investing Cash Flow	-390.89	60	1,077	640.66	-3,168.37	554.16
Share Issuance / Repurchase	38.91	55.71	46.96	3,535	4,325	47
Debt Issued / Paid	559.73	360.77	-65.94	101.53	289.6	34.68
Other Financing Activities	-	-	-	-	588.11	4
Financing Cash Flow	598.64	416.48	-18.97	3,637	5,203	85.68
Exchange Rate Effect	-41.83	-8.08	-69.38	14.04	18.23	-9.51
Net Cash Flow	-736.33	-689.05	-507.85	2,993	769.23	-119.94
Free Cash Flow	-1,499.81	-1,719.35	-1,822.05	-1,561.67	-1,400.97	-839.88
Free Cash Flow Margin	-54.29%	-69.93%	-128.68%	-132.76%	-453.57%	-196.14%
Free Cash Flow Per Share	-14.39	-16.48	-17.67	-16.84	-16.79	-13.99

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).